FindTrial
Sign In

" Reversal of neuromuscular blockade by sugammadex during propofol-remifentanil anaesthesia: Does reversal change bispectral index and entropy levels?"

" Reversal of neuromuscular blockade by sugammadex during propofol-remifentanil anaesthesia: Does reversal change bispectral index and entropy levels?"

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-009605-25-FI
Enrollment
Unknown
Registered
2009-02-03
Start date
2009-09-23
Completion date
Unknown
Last updated
2012-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who will be included in this study are scheduled for elective surgery within the field of ear-, nose and throat (ENT) surgery. No particular medical conditions are to be investigated.

Interventions

Trade Name: Bridion Pharmaceutical Form: INN or Proposed INN: sugammadex

Sponsors

Hanna Illman
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026